Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of recombinant human B lymphocyte stimulator receptor–antibody fusion protein in systemic lupus erythematosus
CTR20191388Phase 3Completed
- Sponsor
- RemeGen
- Start
- Jul 2019
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of atacicept in systemic lupus erythematosus (SLE), sponsored by RemeGen. Started Jul 2019; status: completed.
02
Drugs
atacicept
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20191388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191388.